Search Results 141-150 of 16337 for Interindividual
About this study. Can the genetic makeup of an individual who does not yet have cancer provide an indication of the risk of future cancer?
Learn about possible causes of the loss of bladder control and what treatments are available for this problem.
This is a Phase 1, open-label, first-in-human (FIH) dose-escalation study designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics ...
Learn about these growths that form in or near nerves connecting to the spinal cord. Surgery is the most common treatment.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
1 Diabetes (T1D). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns ...
About this study. This study consists of two phases: Dose Escalation (Phase 1b) and Dose Expansion (Phase 2) The Dose Escalation phase will evaluate the ...
In the Pediatric Advisory Board, children advise Mayo Clinic investigators on their pediatric research to make sure it reflects kids' thoughts, addresses their ...
At the start of the COVID-19 pandemic, life for many people changed very quickly. Worry and concern were natural partners of all that change — getting used ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.